🇺🇸 FDA
Patent

US 11717558

Nucleic acid molecules encoding activin receptor type IIA variants

granted A61KA61K38/00A61K38/18

Quick answer

US patent 11717558 (Nucleic acid molecules encoding activin receptor type IIA variants) held by Keros Therapeutics, Inc. expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Keros Therapeutics, Inc.
Grant date
Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K38/18, A61K47/64, A61K47/65